1. Lifestyle Drugs

   • Devora Mitrany

   Current Opinion 23 September 2012 Pages: 441 - 448

2. Hip Fracture Prevention

   • Peter Vestergaard
   • Lars Rejnmark
   • Leif Mosekilde

   Review Article 23 September 2012 Pages: 449 - 468

   

3. Cost Considerations in the Use of Anaesthetic Drugs

   • Ian Smith

   Review Article 23 September 2012 Pages: 469 - 481

   

4. The Lifetime Cost of Bipolar Disorder in the US

   • Charles E. Begley
   • John F. Annegers
   • Lynda Bryant-Comstock

   Original Research Article 23 September 2012 Pages: 483 - 495

   

5. Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension

   • Peter K. Schädlich
   • Josef Georg Brecht
   • Eduard Huppertz

   Original Research Article 23 September 2012 Pages: 497 - 512

   

6. The Cost of Inadequate Prescriptions for Hypolipidaemic Drugs

   • Luisa Cabello Ballesteros
   • M. Isabel Fernández San Martín
   • VICAF Group

   Original Research Article 23 September 2012 Pages: 513 - 522

   

7. Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients

   • Petra J. van Enckevort
   • Jan H. Zwaveling
   • Elisabeth M. TenVergert

   Original Research Article 23 September 2012 Pages: 523 - 530

   

8. Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS

   • Todd A. Lee
   • Sean D. Sullivan
   • Todd Williamson

   Original Research Article 23 September 2012 Pages: 535 - 550

   

9. Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

   • Michael Iskedjian
   • Thomas R. Einarson
   • Andrew Rosner

   Original Research Article 23 September 2012 Pages: 551 - 563

   

10. Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women

    • Douglas Coyle
    • Ann Cranney
    • Peter Tugwell

    Original Research Article 23 September 2012 Pages: 565 - 575

    

11. Gastrointestinal-Related Healthcare Resource Usage Associated with a Fixed Combination of Diclofenac and Misoprostol versus Other NSAIDs

    • Elham Rahme
    • Lawrence Joseph
    • Jacques LeLorier

    Original Research Article 23 September 2012 Pages: 577 - 588

    

12. Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery

    • Lars-Åke Levin
    • David Bergqvist

    Original Research Article 23 September 2012 Pages: 589 - 597

    

13. The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis

    • Leona Hakkaart-van Roijen
    • Paul Verboom
    • Frans F. H. Rutten

    Original Research Article 23 September 2012 Pages: 599 - 608